Q2 2023 · 13F-HR
Blue Water Life Science Advisors, LPholdings as filed
Filed 2023-08-14 · accession 0001172661-23-003180
$148.2M
Reported value
7
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 632307104 | NTRA | NATERA INC | $42.9M | 28.9% | 881,436 | Common | SOLE |
| 00974H104 | — | AKOYA BIOSCIENCES INC | $34.7M | 23.4% | 4,697,785 | Common | SOLE |
| 40131M109 | GH | GUARDANT HEALTH INC | $24.2M | 16.3% | 676,047 | Common | SOLE |
| 00650F109 | ADPT | ADAPTIVE BIOTECHNOLOGIES COR | $20.3M | 13.7% | 3,030,434 | Common | SOLE |
| 63009R109 | NSTGEUR | NANOSTRING TECHNOLOGIES INC | $11.0M | 7.45% | 2,726,891 | Common | SOLE |
| 57777K106 | MXCT | MAXCYTE INC | $8.7M | 5.84% | 1,885,000 | Common | SOLE |
| 835431107 | — | SONENDO INC | $6.3M | 4.26% | 4,643,461 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.